Leo Verhagen Metman
Overview
Explore the profile of Leo Verhagen Metman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munoz M, Arora R, Rivera Y, Drane Q, Pal G, Verhagen Metman L, et al.
Front Neurol
. 2025 Jan;
15:1463970.
PMID: 39744112
Introduction: The long-term effects of surgery for subthalamic nucleus deep brain stimulation (STN-DBS) on cognitive aspects of motor control for people with Parkinson's disease (PD) are largely unknown. We compared...
2.
Karl J, Joyce J, Ouyang B, Gill C, Verhagen Metman L
Mov Disord Clin Pract
. 2024 Jun;
11(8):992-997.
PMID: 38853400
Background: In our early experience programming directional deep brain stimulation (d-DBS) in PD, we found the optimal directional segment changed over time in some patients. To determine the frequency/reasons for...
3.
Shah-Zamora D, Karl J, Pearce 3rd J, Verhagen Metman L
Mov Disord Clin Pract
. 2024 May;
11(8):1049-1052.
PMID: 38818753
No abstract available.
4.
Munoz M, Reilly J, Pal G, Verhagen Metman L, Sani S, Rosenow J, et al.
Clin Neurophysiol
. 2024 Mar;
162:41-52.
PMID: 38555666
Objective: We aimed to gain further insight into previously reported beneficial effects of subthalamic nucleus deep brain stimulation (STN-DBS) on visually-guided saccades by examining the effects of unilateral compared to...
5.
Verhagen Metman L, Monje M, Obeso J, Martinez-Fernandez R
Parkinsonism Relat Disord
. 2024 Feb;
121:106023.
PMID: 38320923
No abstract available.
6.
Pal G, Corcos D, Verhagen Metman L, Israel Z, Bergman H, Arkadir D
Mov Disord
. 2023 Nov;
38(12):2155-2162.
PMID: 37916476
Genetic subtyping of patients with Parkinson's disease (PD) may assist in predicting the cognitive and motor outcomes of subthalamic deep brain stimulation (STN-DBS). Practical questions were recently raised with the...
7.
Munoz M, Arora R, Rivera Y, Drane Q, Pal G, Verhagen Metman L, et al.
Front Hum Neurosci
. 2023 Oct;
17:1224611.
PMID: 37850040
Background: Antiparkinson medication and subthalamic nucleus deep brain stimulation (STN-DBS), two common treatments of Parkinson's disease (PD), effectively improve skeletomotor movements. However, evidence suggests that these treatments may have differential...
8.
Pal G, David F, Shils J, Munoz M, Afshari M, Sani S, et al.
Mov Disord
. 2023 Jul;
38(6):1113-1114.
PMID: 37475610
No abstract available.
9.
Munoz M, Reilly J, Pal G, Verhagen Metman L, Rivera Y, Drane Q, et al.
Clin Neurophysiol
. 2022 Aug;
143:145-153.
PMID: 35995722
Objective: We examined whether previous inconsistent findings about the effect of anti-Parkinsonian medication on visually-guided saccades (VGS) were due to the use of different paradigms, which change the timing of...
10.
Karl J, Joyce J, Ouyang B, Verhagen Metman L
Neurol Ther
. 2022 Jul;
11(3):1309-1318.
PMID: 35776383
Introduction: Directional deep brain stimulation (d-DBS) axially displaces the volume of tissue activated (VTA) towards the intended target and away from neighboring structures potentially improving benefit and reducing side effects...